During the past decade, John Muir Medical Center-Walnut Creek conducted 29 clinical trials. In the 10-year time frame, 29 clinical trials started and 34 clinical trials were completed, i.e. on average, 117.2% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 19 clinical trials were completed. i.e. 211.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "John Muir Medical Center-Walnut Creek" #1 sponsor was "National Cancer Institute (NCI)" with 34 trials, followed by "GOG Foundation" with 5 trials sponsored, "Gynecologic Oncology Group" with 5 trials sponsored, "Alliance for Clinical Trials in Oncology" with 4 trials sponsored and "NRG Oncology" with 4 trials sponsored. Other sponsors include 15 different institutions and companies that sponsored additional 18 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "John Muir Medical Center-Walnut Creek" #1 collaborator was "National Cancer Institute (NCI)" with 27 trials as a collaborator, "NRG Oncology" with 19 trials as a collaborator, "Cancer and Leukemia Group B" with 4 trials as a collaborator, "Radiation Therapy Oncology Group" with 4 trials as a collaborator and "SWOG Cancer Research Network" with 4 trials as a collaborator. Other collaborators include 42 different institutions and companies that were collaborators in the rest 45 trials.

According to Clinical.Site data, the most researched conditions in "John Muir Medical Center-Walnut Creek" are "Endometrial Serous Adenocarcinoma" (7 trials), "Fallopian Tube Mucinous Adenocarcinoma" (7 trials), "Ovarian Seromucinous Carcinoma" (7 trials), "Endometrial Clear Cell Adenocarcinoma" (6 trials) and "Fallopian Tube Endometrioid Adenocarcinoma" (6 trials). Many other conditions were trialed in "John Muir Medical Center-Walnut Creek" in a lesser frequency.

Most popular intervention types in "John Muir Medical Center-Walnut Creek" are "Drug" (57 trials), "Other" (55 trials), "Biological" (31 trials), "Radiation" (19 trials) and "Procedure" (17 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (30 trials), "Quality-of-Life Assessment" (29 trials), "Paclitaxel" (19 trials), "Carboplatin" (15 trials) and "Bevacizumab" (14 trials). Other intervention names were less common.

The vast majority of trials in "John Muir Medical Center-Walnut Creek" are 38 trials for "All" genders, 33 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "John Muir Medical Center-Walnut Creek". undefined are not yet recruiting, 8 are recruiting, 31 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 29 completed trials in John Muir Medical Center-Walnut Creek, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in John Muir Medical Center-Walnut Creek, 0 "Phase 1" clinical trials were conducted, 21 "Phase 2" clinical trials and 44 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 7 trials that are defined as “Not Applicable".